“The almost 40% growth comes from the sales of hepatitis C products in the Sensiblu network and other pharmacies last year, which cost quite a lot. We saw more than 14% growth on this portfolio, higher than the market. We also grew because of the rise in the number of pharmacies and because of the actual rise in the sales of the existing pharmacies,” Robert Popescu, CEO of the A&D Pharma group, which includes wholesaler Mediplus, and the Sensiblu and Punkt pharmacy chains, told ZF.
Sensiblu is aiming for about EUR20 million higher sales this year, as well as an increase in the number of pharmacies to more than 500 in Romania.
“We are interested in the big cities and want to continue development. We have a strategic partnership with malls and also partnerships with Carrefour, Kaufland. If we know a shopping center is to be developed, we get ready for development.”
(English version by Loredana Fratila-Cristescu)